No, Evolut had a DVI of 0.61, we had 0.62.
its interesting to note Evolut has superior metrics to Sapien, yet Sapien has greater market share.
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial, page-40
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.4M | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.30 | $17.86 | $53.98K | 2.998K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.05 | 51 | 2 |
View Market Depth
| Last trade - 13.02pm 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |